A 2026 clinical trial tested Anulom Vilom pranayama on panic disorder. Symptom scores fell 50 percent.
The paper is open in front of me as I write this. Bose and Ali, International Journal of Indian Psychology 2026, Volume 14(1), pages 895 to 904. The title names the technique. The intervention is the practice. The outcomes are clinical.
This is the first time the app’s exact technique has appeared in a study title in a peer-reviewed psychology journal alongside hard clinical scales. So the question worth asking carefully is what the numbers actually mean.
The three numbers, in order of magnitude
The researchers used three standardised clinical measures, all of them familiar to any psychiatrist:
- PHQ-PD (Patient Health Questionnaire, Panic Disorder module): scores fell 50 percent.
- HAM-A (Hamilton Anxiety Rating Scale): scores fell 45 percent.
- HAM-D (Hamilton Depression Rating Scale): scores fell 40 percent.
Each change was statistically significant (p less than 0.001) with substantial effect sizes. The researchers framed the intervention as accessible and non-invasive with outcomes “comparable to standard pharmacotherapy and cognitive behavioural therapy.”
That phrase (“comparable to standard pharmacotherapy”) is unusual to see in a breathwork study because the comparison set in mainstream anxiety research is usually drug trials reporting effect sizes between 0.3 and 0.5. A 50 percent drop on a validated panic disorder scale sits on the higher end of what gets reported anywhere in the anxiety literature, drug or behavioural.
What anulom vilom actually is
If you have arrived here through the panic disorder route rather than the yoga route, the practice itself is almost embarrassingly simple. You close your right nostril with your right thumb. You inhale slowly through the left. You close your left nostril with the ring finger of the same hand. You exhale slowly through the right. You inhale through the right. You switch. You exhale through the left.
That is one round. The practice in the study used multiple rounds at a slow nasal pace.
The Sanskrit name (anulom vilom, or in its better-known transliteration anuloma viloma) means “with the grain, against the grain.” It is the alternate-nostril branch of pranayama and has been catalogued in Indian yogic texts for roughly two and a half thousand years. Modern breathwork apps tend to call this same technique “alternate nostril breathing.” The wellness industry has occasionally rebranded portions of the broader pranayama tradition as cardiac coherence, box breathing, 4-7-8, cyclic sighing, and most recently as nasal breathing protocols. The lineage runs in one direction.
Why panic disorder is the right population to test it on
Panic disorder is hyperventilation. The body interprets the chemistry of an over-breath as a survival threat. Heart rate climbs. CO2 falls. The vagus nerve disengages from its calming role. The pre-frontal cortex loses its grip on the amygdala. The system unloads.
If you ask a panic disorder patient to slow their nasal breathing during a flare, you are intervening at the exact lever the disorder is using against them. You are restoring CO2 tolerance, re-engaging the vagus, returning the autonomic balance toward parasympathetic. Anulom vilom adds one more variable: the alternation between nostrils, which other research has linked to differential activation across the two cerebral hemispheres.
A 50 percent drop on PHQ-PD is what you would predict from the mechanism, if the mechanism is correct.
Comparable, comparable to what
The paper’s framing of the intervention as “comparable” to standard pharmacotherapy deserves a careful read. The researchers are not claiming that pranayama replaces psychiatric medication. They are reporting that across the three scales they measured, the intervention group’s improvements were not noticeably smaller than what mainstream pharmacotherapy trials report on the same scales in similar populations.
That is a different statement. It is a quieter one. But it lands.
Two reasons to take it seriously even if you are sceptical of breathwork research generally:
- The scales are not soft. HAM-A and HAM-D are the workhorses of psychiatric clinical trials. They are administered by clinicians, not self-reported by enthusiasts.
- The intervention has no obvious placebo confound. Breathwork tells the body to do something specific. Either CO2 changes, or it does not. Either heart rate variability shifts, or it does not. Either the patient stops hyperventilating during a flare, or they keep flaring.
Where the study is silent
The paper does not (in this 2026 iteration) follow patients out past the intervention window long enough to tell us whether the gains hold at 12 months or 24. It does not, in this paper, dismantle the active ingredient (which percentage of the effect is the alternate nostril component versus the slow pacing versus the focused attention). It does not stack pranayama against CBT in a head-to-head and tell us which moves the needle further.
Those are the next studies. They are likely coming. The 2025 Frontiers in Psychiatry systematic review and meta-analysis of pranayama across mental disorder categories is already on the table, and several other RCTs are recruiting in 2026 to 2027.
What this paper does, that no prior paper had done in the same crisp form, is name the technique. By name. In the title. And then attach 50, 45, and 40 to it.
What it means if you have panic attacks
Nothing in this article is medical advice. The clinical decision about how to treat panic disorder belongs to the patient and their clinician. If you are on medication for it, do not stop. If you are mid-attack right now, breathing slowly through alternate nostrils is a reasonable thing to try (the worst-case scenario is that you spent 60 seconds calmly closing one nostril at a time and nothing dramatic happened).
What the paper does suggest is that this 2,500-year-old practice belongs on the same shelf as the standard tools, not as a replacement for them but as something a clinician could prescribe in addition to medication and CBT, with reasonable expectation of measurable benefit.
That is a quiet kind of news. But it is news.
Anuloma Viloma Timer is free on the App Store. No subscription necessary.